| 前收市價 | 1.6500 |
| 開市 | 1.4500 |
| 買盤 | 1.3000 |
| 賣出價 | 1.9500 |
| 拍板 | 3.00 |
| 到期日 | 2024-06-21 |
| 今日波幅 | 1.4500 - 1.6500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 9 |
InvestorPlace7 A-Rated Biotech Stocks Worth Betting on in June
Let me be clear: investing in biotech stocks isn’t for everyone. Investing in smaller biotech companies requires research, patience, and risk tolerance. Investing in A-rated biotech stocks offers high return potential if they make significant advancements in health care. Biotech stocks represent companies that are involved in the research and development of drugs, therapies and medical devices. They include companies that work in fields such as genomics, biopharmaceuticals, bioinformatics and me
ZacksIs Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?
Here is how Atossa Genetics Inc. (ATOS) and Ocugen (OCGN) have performed compared to their sector so far this year.
ZacksOcugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why
Ocugen's (OCGN) shares rise significantly in the year-to-date period on positive progress with its promising pipeline candidates.
